.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Boehringer Ingelheim
AstraZeneca
Express Scripts
Chinese Patent Office
QuintilesIMS
Healthtrust
Merck
Moodys

Generated: September 23, 2017

DrugPatentWatch Database Preview

XYLOCAINE 4% PRESERVATIVE FREE Drug Profile

« Back to Dashboard

What is the patent landscape for Xylocaine 4% Preservative Free, and what generic Xylocaine 4% Preservative Free alternatives are available?

Xylocaine 4% Preservative Free is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in XYLOCAINE 4% PRESERVATIVE FREE is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

Summary for Tradename: XYLOCAINE 4% PRESERVATIVE FREE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list32
Clinical Trials: see list9,209
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:XYLOCAINE 4% PRESERVATIVE FREE at DailyMed

Pharmacology for Tradename: XYLOCAINE 4% PRESERVATIVE FREE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
XYLOCAINE 4% PRESERVATIVE FREE
lidocaine hydrochloride
INJECTABLE;INJECTION010417-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
XYLOCAINE 4% PRESERVATIVE FREE
lidocaine hydrochloride
SOLUTION;TOPICAL010417-002Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
UBS
Moodys
US Army
Daiichi Sankyo
Medtronic
Argus Health
Baxter
Farmers Insurance
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot